Loading stock data…
XRAY
$11.14-0.23 (-2.02%)
DENTSPLY SIRONA Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
DENTSPLY SIRONA Inc. in the Healthcare sector is trading at $11.14. The stock is currently near its 52-week low of $9.85, remaining 10.2% below its 200-day moving average. Technical signals show neutral RSI of 36 and bearish MACD signal, explaining why XRAY maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 36) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$11.14
Potential Upside
5%
Whystock Fair Value$11.70
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus15 analysts
Hold
Mean target$13.67+22.7%
Range$10.50 – $18.00
Fundamentals
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Tech...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.38B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
1.00
Div Yield
Strong income play. Yield provides a meaningful total return floor.
504.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-70.87%
Volume
Today's trading volume
7.96M
Recent News
XRAY Stock Down as Q1 Earnings Miss Estimates, Margins Contract
DENTSPLY SIRONA stock slips after Q1 earnings miss estimates as margin pressure offsets revenue growth in key healthcare segments.
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript
Joining me for today's call are Daniel T. Scavilla and Michael Pomeroy, Interim Chief Financial Officer. Before we begin, please take a moment to read the forward-looking statements in our earnings press release. During today's call, we may make certain forward-looking statements that reflect our current views about future performance and financial results.
DENTSPLY SIRONA Q1 Earnings Call Highlights
DENTSPLY SIRONA (NASDAQ:XRAY) reported first-quarter 2026 results that management characterized as the opening phase of its “Return-to-Growth” action plan, with leadership emphasizing that many of the operational and commercial actions underway are not yet fully reflected in financial performance.
DENTSPLY SIRONA Inc. Q1 2026 Earnings Call Summary
Moby summary of DENTSPLY SIRONA Inc.'s Q1 2026 earnings call
Dentsply (XRAY) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.